
SNGX
Healthcare · Biotechnology · $7.5M market cap
$0.3210+0.00 (+0.3%)Nov 13, 4:24 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 6, 2026 | After the close | -0.12 | -0.05 | +58.3% |
| Aug 7, 2026 | Time not confirmed | -0.22 | -0.12 | +45.5% |
| May 8, 2026 | After the close | -0.30 | -0.28 | +6.7% |
| Nov 7, 2025 | After the close | -0.48 | -0.58 | -20.8% |
| Aug 14, 2025 | After the close | -1.05 | -0.82 | +21.9% |
| May 9, 2025 | After the close | -0.67 | -1.06 | -58.2% |
| Mar 13, 2025 | Before the open | -1.56 | -1.14 | +26.9% |
| Nov 8, 2024 | After the close | -1.69 | -0.78 | +53.8% |
| Aug 9, 2024 | After the close | -1.77 | -1.31 | +26.0% |
| May 10, 2024 | After the close | -0.19 | -0.18 | +5.3% |
| Mar 15, 2024 | After the close | -3.12 | -2.56 | +17.9% |
| Nov 13, 2023 | After the close | -4.64 | -2.56 | +44.8% |
| Aug 21, 2023 | Before the open | -6.08 | -3.52 |
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of…
| +42.1% |
| May 15, 2023 | Before the open | -20.00 | -5.76 | +71.2% |
| Mar 31, 2023 | Before the open | -1.12 | -4.58 | -308.9% |
| Nov 10, 2022 | After the close | -21.60 | -19.20 | +11.1% |
| Aug 12, 2022 | After the close | -24.00 | -13.58 | +43.4% |
| May 13, 2022 | After the close | -19.20 | -24.62 | -28.2% |
| Mar 29, 2022 | Before the open | -1.20 | -1.65 | -37.5% |
| Nov 12, 2021 | After the close | -19.20 | -21.00 | -9.4% |
| Aug 13, 2021 | Before the open | -26.40 | -12.00 | +54.5% |
| May 18, 2021 | Before the open | -16.80 | -15.96 | +5.0% |
| Mar 30, 2021 | Before the open | -1.20 | -2.40 | -100.0% |
| Nov 12, 2020 | Before the open | -33.60 | -14.71 | +56.2% |
| Aug 14, 2020 | After the close | -38.40 | -25.08 | +34.7% |
| May 15, 2020 | After the close | -36.00 | -26.81 | +25.5% |
| Mar 30, 2020 | Before the open | -1.99 | -2.10 | -5.5% |
| Nov 12, 2019 | After the close | -33.60 | -33.60 | 0.0% |
| Aug 13, 2019 | After the close | -33.60 | -28.80 | +14.3% |
| May 14, 2019 | After the close | 40.80 | -21.60 | -152.9% |
| Mar 26, 2019 | After the close | -2.25 | -2.70 | -20.0% |
| Nov 9, 2018 | Before the open | -24.00 | -26.40 | -10.0% |
| Aug 8, 2018 | Before the open | -48.00 | -43.20 | +10.0% |
| May 11, 2018 | Before the open | -0.25 | -0.27 | -8.0% |
| Mar 15, 2018 | After the close | -69.60 | -64.80 | +6.9% |